B
VIRX
Bailard’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,899
| Closed | -$12.4K | – | 825 |
|
|
2023
Q3 | $12.4K | Sell |
11,899
-35,801
| -75% | -$37.2K | ﹤0.01% | 694 |
|
|
2023
Q2 | $67.3K | Buy |
47,700
+27,800
| +140% | +$39.2K | ﹤0.01% | 674 |
|
|
2023
Q1 | $31.6K | Buy |
+19,900
| New | +$31.6K | ﹤0.01% | 709 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$401K | – | 800 |
|
|
2021
Q3 | $401K | Sell |
50,000
-95,000
| -66% | -$762K | 0.01% | 451 |
|
|
2021
Q2 | $1.64M | Buy |
145,000
+108,000
| +292% | +$1.22M | 0.06% | 224 |
|
|
2021
Q1 | $342K | Buy |
+37,000
| New | +$342K | 0.01% | 474 |
|